Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients |
| |
| Authors: | Ben W. Mol,Patrick M. Bossuyt,Sesh K. Sunkara,Juan A. Garcia Velasco,Christos Venetis,Denny Sakkas,Kersti Lundin,Carlos Simón,Hugh S. Taylor,Robert Wan,Salvatore Longobardi,Evelyn Cottell,Thomas D&#x Hooghe |
| |
| Affiliation: | 1. Monash University, Clayton, Victoria, Australia;2. University of Amsterdam, Amsterdam, the Netherlands;3. Queen''s Hospital, Barking, Havering and Redbridge University Hospitals, Essex, United Kingdom;4. IVI RMA Madrid and Rey Juan Carlos University, Madrid, Spain;5. University of New South Wales, Sydney, New South Wales, Australia;6. Boston IVF, Waltham, Massachusetts;7. Sahlgrenska University Hospital, Goteborg, Sweden;8. Igenomix, Valencia University, Valencia, Spain;9. Yale University Medical School, New Haven, Connecticut;10. EMD Serono, Billerica, Massachusetts;11. Global Medical Affairs Fertility, Research and Development, Merck KGaA, Darmstadt, Germany;12. Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, Belgium;13. Department of Obstetrics and Gynecology, Yale University, New Haven, Connecticut |
| |
| Abstract: | |
| |
| Keywords: | Personalized medicine precision medicine trial design ART |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
